Why the study?
The study was conducted to compare clinical and radiological outcomes of Pavlik harness treatment in infants aged 0-6 months with developmental dysplasia of the hip with the literature and evaluate the effect of patient variables on outcomes.
Does Pavlik harness treatment improve clinical and radiological outcomes in infants aged 0-6 months with developmental dysplasia of the hip?
Does Pavlik harness treatment improve clinical and radiological outcomes in infants aged 0-6 months with developmental dysplasia of the hip?
Pavlik harness is an effective treatment for developmental dysplasia of the hip in infants, though Graf type III classification and limitation of abduction significantly increase the risk of treatment failure.
Pavlik harness yielded 88% success in early DDH; supports routine use but leaves open failure predictors like Graf III for prospective validation.
Developmental dysplasia of the hip (DDH) is the most common developmental abnormality that affects the hip. The aim of the treatment of DDH is to achieve the anatomical reduction for normal development of femoral head and acetabulum in the soonest possible time and to maintain this reduction. Therefore, Pavlik harness is primarily preferred. In the present study, it was aimed to compare the clinical and radiological results with literatre in the 0-6 month patients with DDH who were treated using Pavlik harness and also to investigate the effects of the patient variables on treatment outcomes. 82 hips of the 52 patients treated and followed-up by two authors were included in the study. The data from the patient files such as age at diagnosis, ultrasonography (US) type according to the Graf method, treatment duration, the findings of physcial examination, risk factors and presence of avascular necrosis (AVN) were analyzed. According to the Graf method; 2, 38, 33 and 9 hips were classified as type IIa-, IIb, IIc and III, respectively. Pavlik harness treatment was accepted successful in 72 (87.8%) hips whereas treatment was considered unsuccessful in 10 (12.2%) hips. The rate of type IIb hip was significantly higher in the successful treatment group. The rate of treatment failure was significantly higher in the type III hip. We have concluded that presence of limitation of abduction and Graf type III hip increased the rate of treatment failure in the Pavlik harness treatment of DDH.
No takes yet. Share an insight, caveat, or question.
Türközü et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: